The history of the erectile dysfunction drug presents a complex picture for shareholders. While the initial launch generated substantial gains, the lapse of its intellectual property protection opened the avenue to https://dawudzknp392189.ja-blog.com/42124060/sildenafil-and-big-pharma-a-volatile-bet